These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36600473)

  • 41. Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome.
    Abdel-Latif ME; Davis PG; Wheeler KI; De Paoli AG; Dargaville PA
    Cochrane Database Syst Rev; 2021 May; 5(5):CD011672. PubMed ID: 33970483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel Ventilation Strategies to Reduce Adverse Pulmonary Outcomes.
    Keszler M
    Clin Perinatol; 2022 Mar; 49(1):219-242. PubMed ID: 35210003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gentle ventilation: the new evidence from the SUPPORT, COIN, VON, CURPAP, Colombian Network, and Neocosur Network trials.
    Carlo WA
    Early Hum Dev; 2012 May; 88 Suppl 2():S81-3. PubMed ID: 22633522
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Compared to CPAP extubation to non-invasive ventilation is associated with higher risk of bronchopulmonary dysplasia in extremely low birth weight infants.
    Abu-Shaweesh JM; Khasawneh W; Tang AS; Worley S; Saker F
    J Neonatal Perinatal Med; 2020; 13(2):183-188. PubMed ID: 31658069
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of the effects of invasive mechanic ventilation/surfactant therapy and non-invasive nasal-continuous positive airway pressure in preterm newborns.
    Celik M; Bulbul A; Uslu S; Dursun M; Guran O; Kıray Bas E; Arslan S; Zubarioglu U
    J Matern Fetal Neonatal Med; 2018 Dec; 31(24):3225-3231. PubMed ID: 28856971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Respiratory management in the premature neonate.
    Dumpa V; Avulakunta I; Bhandari V
    Expert Rev Respir Med; 2023 Feb; 17(2):155-170. PubMed ID: 36803028
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-Invasive Ventilation in Neonatology.
    Behnke J; Lemyre B; Czernik C; Zimmer KP; Ehrhardt H; Waitz M
    Dtsch Arztebl Int; 2019 Mar; 116(11):177-183. PubMed ID: 31014448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nasal CPAP and surfactant for treatment of respiratory distress syndrome and prevention of bronchopulmonary dysplasia.
    Verder H; Bohlin K; Kamper J; Lindwall R; Jonsson B
    Acta Paediatr; 2009 Sep; 98(9):1400-8. PubMed ID: 19572989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Respiratory support in preterm infants at birth.
    ;
    Pediatrics; 2014 Jan; 133(1):171-4. PubMed ID: 24379228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction between surfactant and ventilatory support in newborns with primary surfactant deficiency.
    Plavka R; Keszler M
    Biol Neonate; 2003; 84(1):89-95. PubMed ID: 12890943
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comprehensive approach to the prevention of bronchopulmonary dysplasia.
    Kugelman A; Durand M
    Pediatr Pulmonol; 2011 Dec; 46(12):1153-65. PubMed ID: 21815280
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Noninvasive Support: Does It Really Decrease Bronchopulmonary Dysplasia?
    Wright CJ; Polin RA
    Clin Perinatol; 2016 Dec; 43(4):783-798. PubMed ID: 27837759
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ancillary therapies to enhance success of non-invasive modes of respiratory support - Approaches to delivery room use of surfactant and caffeine?
    Kribs A; Hummler H
    Semin Fetal Neonatal Med; 2016 Jun; 21(3):212-8. PubMed ID: 26936187
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of Minimally Invasive Surfactant Therapy in Preterm Infants at 29-32 Weeks Gestation.
    Dargaville PA; Ali SKM; Jackson HD; Williams C; De Paoli AG
    Neonatology; 2018; 113(1):7-14. PubMed ID: 28922658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Failure of non-invasive continuous positive airway pressure as the initial respiratory support in very preterm infants: a multicenter prospective cohort study].
    Multicenter Study Collaborative Group for Evaluation of Outcomes in Very Low Birth Weight Infants
    Zhonghua Er Ke Za Zhi; 2021 Apr; 59(4):273-279. PubMed ID: 33775045
    [No Abstract]   [Full Text] [Related]  

  • 56. Surfactant, steroids and non-invasive ventilation in the prevention of BPD.
    Dumpa V; Bhandari V
    Semin Perinatol; 2018 Nov; 42(7):444-452. PubMed ID: 30343941
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early respiratory management of respiratory distress syndrome in very preterm infants and bronchopulmonary dysplasia: a case-control study.
    Te Pas AB; Lopriore E; Engbers MJ; Walther FJ
    PLoS One; 2007 Feb; 2(2):e192. PubMed ID: 17285145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surfactant replacement in preterm infants with respiratory distress syndrome.
    Dani C
    Acta Biomed; 2012; 83 Suppl 1():17-20. PubMed ID: 23029871
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimal ventilatory strategies and surfactant to protect the preterm lungs.
    Ramanathan R
    Neonatology; 2008; 93(4):302-8. PubMed ID: 18525214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Non-invasive high-frequency oscillatory ventilation versus nasal continuous positive airway pressure in extremely preterm infants with respiratory distress syndrome: study protocol for a multicentre randomised controlled, superiority trial.
    Li Y; Zhu X; Shi Y;
    BMJ Open; 2023 Mar; 13(3):e068450. PubMed ID: 36868587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.